These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9876596)

  • 1. Alternative solvent-free preparation methods for felodipine surface solid dispersions.
    Kerc J; Srcic S; Kofler B
    Drug Dev Ind Pharm; 1998 Apr; 24(4):359-63. PubMed ID: 9876596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of a solid dispersion of felodipine using a solvent wetting method.
    Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
    Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine.
    Lee KR; Kim EJ; Seo SW; Choi HK
    Arch Pharm Res; 2008 Aug; 31(8):1023-8. PubMed ID: 18787792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.
    Won DH; Kim MS; Lee S; Park JS; Hwang SJ
    Int J Pharm; 2005 Sep; 301(1-2):199-208. PubMed ID: 16024189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods.
    Meng J; Li S; Yao Q; Zhang L; Weng Y; Cai C; Xu H; Tang X
    Drug Dev Ind Pharm; 2014 Jul; 40(7):929-36. PubMed ID: 23614872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the properties of felodipine solid dispersions prepared by different technologies].
    Shi NQ; Zhang H; Zhang Y; Feng B; Li ZQ; Qi XR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1067-1073. PubMed ID: 27987515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid dispersion of spironolactone with porous silica prepared by the solvent method.
    Uchino T; Yasuno N; Yanagihara Y; Suzuki H
    Pharmazie; 2007 Aug; 62(8):599-603. PubMed ID: 17867555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
    Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
    Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screen for Inhibitors of Crystal Growth to Identify Desirable Carriers for Amorphous Solid Dispersions Containing Felodipine.
    Fu J; Cui L; Yang C; Xiong H; Ren G; Ma X; Jing Q; Ren F
    AAPS PharmSciTech; 2018 Apr; 19(3):1231-1242. PubMed ID: 29302871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation by design of felodipine loaded liquid and solid self nanoemulsifying drug delivery systems using Box-Behnken design.
    Verma S; Singh SK; Verma PR; Ahsan MN
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1358-70. PubMed ID: 23879216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.
    Khan GM; Jiabi Z
    Drug Dev Ind Pharm; 1998 May; 24(5):455-62. PubMed ID: 9876608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the ability of PVP/PEG mixtures to be used as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique using artificial neural networks: I.
    Papadimitriou SA; Barmpalexis P; Karavas E; Bikiaris DN
    Eur J Pharm Biopharm; 2012 Sep; 82(1):175-86. PubMed ID: 22732266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of budesonide-poly (ethylene oxide) solid dispersions using supercritical carbon dioxide and in vitro evaluation].
    Liu H; Pan WS; Zhou LL; Zhang ZH
    Yao Xue Xue Bao; 2007 Feb; 42(2):206-10. PubMed ID: 17518053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution.
    Pandey MM; Jaipal A; Charde SY; Goel P; Kumar L
    Pharm Dev Technol; 2016; 21(4):463-74. PubMed ID: 25777532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real time Raman imaging to understand dissolution performance of amorphous solid dispersions.
    Tres F; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
    J Control Release; 2014 Aug; 188():53-60. PubMed ID: 24910191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs.
    Van den Mooter G; Weuts I; De Ridder T; Blaton N
    Int J Pharm; 2006 Jun; 316(1-2):1-6. PubMed ID: 16563676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
    Konno H; Handa T; Alonzo DE; Taylor LS
    Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.
    Hecq J; Deleers M; Fanara D; Vranckx H; Amighi K
    Int J Pharm; 2005 Aug; 299(1-2):167-77. PubMed ID: 15996838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe.
    Sancheti PP; Karekar P; Vyas VM; Shah M; Pore YV
    Pharmazie; 2009 Apr; 64(4):227-31. PubMed ID: 19435139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.